• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

市场份额至关重要:保险公司与医疗服务提供商就价格进行讨价还价的证据。

Market Share Matters: Evidence Of Insurer And Provider Bargaining Over Prices.

作者信息

Roberts Eric T, Chernew Michael E, McWilliams J Michael

机构信息

Eric T. Roberts is a postdoctoral fellow in the Department of Health Care Policy at Harvard Medical School, in Boston, Massachusetts.

Michael E. Chernew is the Leonard D. Schaeffer Professor of Health Care Policy in the Department of Health Care Policy, Harvard Medical School.

出版信息

Health Aff (Millwood). 2017 Jan 1;36(1):141-148. doi: 10.1377/hlthaff.2016.0479.

DOI:10.1377/hlthaff.2016.0479
PMID:28069857
Abstract

Proposed mergers among large US health insurers and growing consolidation among providers have renewed concerns about the effects of market concentration on commercial health care prices. Using multipayer claims for physician services provided in office settings, we estimated that-within the same provider groups-insurers with market shares of 15 percent or more (average: 24.5 percent), for example, negotiated prices for office visits that were 21 percent lower than prices negotiated by insurers with shares of less than 5 percent. Analyses stratified by provider market share suggested that insurers require greater market shares to negotiate lower prices from large provider groups than they do when negotiating with smaller provider groups. For example, office visit prices for small practices were $88, $72, and $70, for insurers with market shares of <5 percent, ≥5 to <15 percent, and ≥15 percent, respectively, whereas prices for large provider groups were $97, $86, and $76, exhibiting a continued decrease across higher insurer-market-share categories. These results suggest that mergers of health insurers could lower the prices paid to providers, particularly providers large enough to obtain higher prices from insurers with modest market shares. Continued monitoring will be important for determining the net effects of the countervailing trends of insurer and provider consolidation on the affordability of health care.

摘要

美国大型健康保险公司之间拟议的合并以及医疗服务提供商之间日益加剧的整合,再次引发了人们对市场集中度对商业医疗保健价格影响的担忧。利用在门诊环境中提供的医生服务的多付款人索赔数据,我们估计,例如,在同一医疗服务提供商群体中,市场份额达到或超过15%(平均为24.5%)的保险公司,其门诊协商价格比市场份额低于5%的保险公司低21%。按医疗服务提供商市场份额分层的分析表明,与小型医疗服务提供商群体谈判时相比,保险公司需要更大的市场份额才能从大型医疗服务提供商群体那里协商到更低的价格。例如,对于小型医疗机构,市场份额<5%、≥5%至<15%以及≥15%的保险公司的门诊价格分别为88美元、72美元和70美元,而对于大型医疗服务提供商群体,价格分别为97美元、86美元和76美元,显示出随着保险公司市场份额类别升高价格持续下降。这些结果表明,健康保险公司的合并可能会降低支付给医疗服务提供商的价格,尤其是那些规模大到足以从市场份额适中的保险公司获得更高价格的医疗服务提供商。持续监测对于确定保险公司和医疗服务提供商整合这两种抵消趋势对医疗保健可负担性的净影响至关重要。

相似文献

1
Market Share Matters: Evidence Of Insurer And Provider Bargaining Over Prices.市场份额至关重要:保险公司与医疗服务提供商就价格进行讨价还价的证据。
Health Aff (Millwood). 2017 Jan 1;36(1):141-148. doi: 10.1377/hlthaff.2016.0479.
2
Insurer Market Power Lowers Prices In Numerous Concentrated Provider Markets.保险市场势力降低了众多集中供应商市场的价格。
Health Aff (Millwood). 2017 Sep 1;36(9):1539-1546. doi: 10.1377/hlthaff.2017.0552.
3
Wide variation in hospital and physician payment rates evidence of provider market power.医院和医生支付费率存在广泛差异,这证明了供应商的市场力量。
Res Brief. 2010 Nov(16):1-11.
4
Hospital prices and market structure in the hospital and insurance industries.医院和保险行业的医院价格和市场结构。
Health Econ Policy Law. 2010 Oct;5(4):459-79. doi: 10.1017/S1744133110000083. Epub 2010 May 18.
5
Do Insurers With Greater Market Power Negotiate Consistently Lower Prices for Hospital Care? Evidence From Hospital Price Transparency Data.保险公司的市场势力越大,是否会一直协商降低医院护理的价格?来自医院价格透明度数据的证据。
Med Care Res Rev. 2024 Feb;81(1):78-84. doi: 10.1177/10775587231193475. Epub 2023 Aug 18.
6
Market Power: Price Variation Among Commercial Insurers For Hospital Services.市场势力:商业保险公司之间医院服务价格的差异。
Health Aff (Millwood). 2018 Oct;37(10):1615-1622. doi: 10.1377/hlthaff.2018.0567.
7
Physician practice competition and prices paid by private insurers for office visits.医生执业竞争与私人保险公司支付的门诊费用。
JAMA. 2014;312(16):1653-62. doi: 10.1001/jama.2014.10921.
8
Insurer Market Power And Hospital Prices In The US.美国的保险公司市场势力与医院价格
Health Aff (Millwood). 2023 May;42(5):615-621. doi: 10.1377/hlthaff.2022.01184.
9
Prices and market power in mental health care: Evidence from a major policy change in the Netherlands.精神卫生保健中的价格和市场势力:来自荷兰重大政策变革的证据。
Health Econ. 2021 Apr;30(4):803-819. doi: 10.1002/hec.4222. Epub 2021 Jan 27.
10
Hospital Prices Grew Substantially Faster Than Physician Prices For Hospital-Based Care In 2007-14.2007-14 年,医院为基础的护理中,医院价格的增长速度大大快于医生价格的增长速度。
Health Aff (Millwood). 2019 Feb;38(2):184-189. doi: 10.1377/hlthaff.2018.05424.

引用本文的文献

1
The moral dilemma of healthcare service utilization: a perspective from the consolidation of urban and rural resident health insurance policy in China.医疗服务利用中的道德困境:来自中国城乡居民医疗保险政策整合的视角
Health Econ Rev. 2025 Feb 18;15(1):10. doi: 10.1186/s13561-025-00591-1.
2
How do hospitals exert market power? Evidence from health systems and commercial health plan prices.医院如何发挥市场力量?来自医疗系统和商业健康保险计划价格的证据。
Health Aff Sch. 2025 Jan 16;3(1):qxae179. doi: 10.1093/haschl/qxae179. eCollection 2025 Jan.
3
Hospital system market share and commercial prices: a cross-sectional approach using price transparency data.
医院系统市场份额与商业价格:一种使用价格透明度数据的横断面研究方法。
Health Econ Rev. 2024 Dec 4;14(1):102. doi: 10.1186/s13561-024-00580-w.
4
Commercial insurers' market power and hospital prices in Medicaid managed care.商业保险公司的市场势力与医疗补助管理式医疗中的医院价格
Health Serv Res. 2025 Feb;60(1):e14407. doi: 10.1111/1475-6773.14407. Epub 2024 Nov 9.
5
Commercial prices and their influence on urology practices: Prostate cancer care among men with Medicare.商业价格及其对泌尿外科医疗实践的影响:医疗保险男性人群中的前列腺癌护理
Cancer. 2025 Jan 1;131(1):e35633. doi: 10.1002/cncr.35633. Epub 2024 Nov 5.
6
Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers.支付方协商价格变化与 NCI 指定癌症中心最常见癌症手术结果的关系。
Ann Surg Oncol. 2024 Jul;31(7):4339-4348. doi: 10.1245/s10434-024-15150-x. Epub 2024 Mar 20.
7
Medical service pricing and pharmaceutical supply chain coordination contracts under the zero-markup drug policy.零差价药品政策下的医疗服务定价和医药供应链协调合同。
Front Public Health. 2023 Oct 19;11:1208994. doi: 10.3389/fpubh.2023.1208994. eCollection 2023.
8
Price setting in the Brazilian private health insurance sector.巴西私营医疗保险领域的价格制定。
Int J Health Econ Manag. 2024 Mar;24(1):57-80. doi: 10.1007/s10754-023-09361-0. Epub 2023 Sep 10.
9
Practice Competition and Treatment of Newly Diagnosed Prostate Cancer.初诊前列腺癌的实践竞争与治疗。
Urology. 2023 Jul;177:95-102. doi: 10.1016/j.urology.2023.04.022. Epub 2023 May 3.
10
Prices and market power in mental health care: Evidence from a major policy change in the Netherlands.精神卫生保健中的价格和市场势力:来自荷兰重大政策变革的证据。
Health Econ. 2021 Apr;30(4):803-819. doi: 10.1002/hec.4222. Epub 2021 Jan 27.